Hook & thesis
Salesforce (CRM) is attractively positioned right now for one straightforward reason: management sits on strong recurring free cash flow while holding equity in a rapidly appreciating AI platform. If that off-market AI stake is at all monetizable, Salesforce gains a realistic route to retire roughly $25 billion in share-repurchase-related obligations without tapping operating cash flow or jeopardizing R&D and partner investments. That optionality matters to valuation because it converts an execution/financing risk into a structural upside trigger.
We think the market is under-pricing that optionality. At a market cap of about $193.1 billion and free cash flow of $15.154 billion, Salesforce already trades at a reasonable multiple for a cloud leader. Monetization of an AI stake or a partial sale could materially de-lever the share-repurchase picture and re-rate the stock higher. This is a long-term trade idea: entry at $234.62, target $270, stop loss $216, with the plan held for the long term (180 trading days).
What Salesforce does and why the market should care
Salesforce builds cloud software for CRM, customer service, marketing automation, digital commerce and enterprise AI-powered agents. The company’s business model is subscription-heavy, recurring and sticky. The market cares because the next several years of enterprise software valuation will be driven by two things: (1) the ability to convert existing ARR into higher-margin AI-enabled services and (2) balance-sheet optionality—specifically, how companies fund growth and capital returns without undermining execution.
For Salesforce, the combination of robust free cash flow and an AI equity position gives management flexibility. If the stake in an AI developer is monetized or used as collateral, it provides a one-off lever to retire buyback-related debt, lower net leverage and improve returns without cutting investment in product or go-to-market.
Hard numbers that matter
| Metric | Value |
|---|---|
| Current price | $234.62 |
| Market capitalization | $193.09B |
| Enterprise value | $227.03B |
| Free cash flow | $15.154B |
| EV / Sales | 5.17x |
| EV / EBITDA | 15.67x |
| P / E | ~20 - 21x |
| Return on equity | 25.18% |
| Debt / Equity | 1.02 |
| Current ratio | 0.84 |
Put simply: $15.154 billion of FCF on a $193 billion market cap implies about a 7.85% FCF yield. That yield gives Salesforce plenty of internal capacity to fund growth while servicing debt. But FCF alone may not be enough or quick enough to address a near-term $25 billion buyback financing stitch; that’s where the optionality of an AI equity position comes into play.
How the Anthropic stake optionality matters (context)
Management-owned or strategic equity stakes in private AI firms can be a de-risking lever: sell a minority tranche, take a secondary into public markets, or use the asset as collateral for structured financing. If Salesforce were to monetize a portion of an Anthropic stake, it could redirect proceeds to accelerate buyback retirement, lower gross leverage and remove a headline risk that weighs on the multiple.
We do not assume a full $25 billion cash paydown is guaranteed. But the existence of a potentially high-value AI equity position is asymmetric: the upside (debt paydown and faster multiple expansion) substantially exceeds the downside (market skepticism and partial dilution from any financing required to monetize). That optionality is the heart of our bullish case.
Valuation framing
Market cap around $193.1B and an EV of $227.0B implies the market views Salesforce as a premium enterprise software franchise. EV/EBITDA of 15.7x and a P/E roughly in the low 20s are consistent with a mature-growth SaaS leader, not a pure high-growth multiple. Given Salesforce’s 25% ROE and $15.154B FCF, the current multiple embeds steady growth but not aggressive multiple expansion.
If management reduces net leverage materially - for example by retiring a meaningful portion of $25B in buyback financing - the multiple could re-rate toward peers that trade at lower perceived execution risk. Conversely, if leverage rises or cash generation softens, multiples should compress.
Catalysts to watch (timelines)
- Monetization or financing announcement for AI equity - any press release or 8-K announcing a sale, secondary, or structured financing could be a major de-risking event (near to medium term).
- Quarterly results showing FCF stability and ARR resilience - solid beats in revenue and FCF will bolster the funding case (each quarter).
- Share-repurchase program updates - explicit disclosure of debt paydown plans or acceleration of buyback retirement (near to medium term).
- Macro rate moves - a meaningful drop in yields could reduce the cost of repurchase financing and improve valuation (near term to medium term).
- Large enterprise AI wins or new AgentExchange partnerships - incremental evidence that AI leads to higher contract values could expand margin expectations (medium term).
Trade plan (actionable)
Entry: Buy CRM at $234.62.
Target: $270.00.
Stop loss: $216.00.
Horizon: Long term (180 trading days). Rationale: the thesis hinges on corporate action (monetization of an AI stake and/or material buyback retirement) and the realization of improved investor sentiment; both are multi-month events. Holding for 180 trading days gives time for quarterly reporting cycles, deal execution windows, and macro moves that influence financing costs.
Sizing and risk management: Position size should reflect that while the balance-sheet case is strong, execution risk is real. Use the stop to limit losses; trim into strength if price approaches the target or if a de-leveraging announcement is made. Re-assess position after any major news event related to AI stake monetization or a buyback update.
Technical and liquidity context
Price sits at $234.62, below short-term moving averages (SMA10 ~$242.65, SMA20 ~$248.14) but above the SMA50 (~$213.69). Momentum indicators are neutral-to-cautious: RSI near 50 and a bearish MACD histogram suggest the stock is not overbought but lacks positive momentum. Average daily volume is roughly 13 million shares; recent trading volumes have been lighter which increases the importance of placing realistic orders. Short interest has come down from higher levels; the most recent settlement shows ~32.35 million shares short with about 2.47 days to cover, implying limited squeeze potential but persistent bearish positioning.
Risks and counterarguments
- Asset illiquidity or governance constraints: The Anthropic stake may be illiquid, contractually restricted, or valued conservatively by prospective buyers. If so, monetization will be slow or receive steep discounts, reducing the practical value of the optionality.
- Execution on buyback/debt retirement: Management could choose not to accelerate debt retirement, prioritizing repurchases or M&A instead. If buybacks continue without deleveraging, the balance-sheet risk remains.
- Macro and rate risk: Rising rates would increase the cost of financing and could push multiples lower across the software sector, offsetting any company-specific improvement.
- Operational slowdown or margin pressure: If AI initiatives or channel investments fail to convert into higher-margin ARR, free cash flow could compress, weakening the funding base for any debt retirements.
- Counterargument: Even if management cannot or will not monetize an AI stake, Salesforce’s significant FCF ($15.154B) and high ROE (25.18%) provide a durable runway to service buyback financing and continue to fund growth. In that case the company still merits a stable valuation; the lack of a monetization event simply reduces upside but doesn’t turn the thesis negative.
What would change my mind
I will lower the target and shift to neutral/short if any of the following occur: (1) management explicitly signals an intention to increase leverage to fund buybacks rather than repaying debt; (2) quarterly FCF falls materially below guidance; (3) the company discloses insurmountable restrictions on monetizing AI equity; or (4) macro tightening materially lifts the cost of repurchase financing and results in multiple compression across the sector.
Conclusion
Salesforce is a long-term buy at $234.62 on the basis that its free cash flow profile and the optionality embedded in an AI equity position create a path to materially de-risk $25 billion of repurchase financing. The market currently prices CRM like a mature cloud leader but doesn't give substantial credit for an optional, off-balance-sheet path to de-levering. If management monetizes that position or accelerates debt retirement, the stock should re-rate. Keep the trade horizon to long term (180 trading days), use a $216 stop, and a $270 target, and re-evaluate after any major corporate action.
Key dates to watch: upcoming quarterly results and any financing or asset sale announcements through 10/08/2026 (payable date) and subsequent quarters.